CME

Reynolds Delgado, MD, FACC The Texas Heart Institute Houston, TX Overview: Describe three new innovations in cardiovascular medicine. Discuss the first human use of the BIVACOR total artificial heart. Objectives: At the conclusion of the activity a participant should be able to: Describe three new innovations in cardiovascular medicine--Procyrion, Anaxiom, and BIVACOR Discuss the first...

Pradeep Natarajan, MD, MMSC Massachusetts General Hospital Boston, MA Overview: Somatic mutations indicative of clonal hematopoiesis have emerged as a novel risk factor for atherosclerotic cardiovascular disease. This talk will cover its discovery, biology, and clinical implications for the prevention and atherosclerotic cardiovascular disease. Objectives: At the conclusion of the activity a participant should be...

Javed Butler, MD, MPH, MBA Baylor, Scott & White Research Institute Dallas, TX Overview: In recent years, the CV mortality at a population level has worsened and almost all risk factors for CV diseases are now more prevalent. Moreover, large care gaps exists for these diseases. The grand round will focus on current trends and...

Ajith Nair, MD, FACC, FAHA Baylor College of Medicine Houston, TX Overview: This lecture will discuss the impact of pulmonary hypertension on left heart disease. The lecture will Highlight changes in the ESC guidelines for the diagnosis of pulmonary hypertension including the role of Exercise hemodynamics. Therapeutic approaches to the management of LHD and PH...

Jennifer Cozart, MD The Texas Heart Institute Center for Cardiovascular Care Houston, TX Overview: An overview of the evolution of surgical treatment of atrial fibrillation with a focus on new therapies. Objectives: At the conclusion of the activity a participant should be able to: Assess patients with atrial fibrillation Determine the appropriate candidates for surgical...